PriceSensitive

HYTN Innovations (CSE:HYTN) begins accepting orders directly from provinces and territories

Cannabis
CSE:HYTN
17 March 2022 12:00 (EDT)

Source: LinkedIn

HYTN Innovations (HYTN) has begun accepting orders directly from provincial buyers.

This news builds on HYTN’s February 22 announcement that it had been awarded approval to sell cannabis products provincially and territorially to authorized retailers.

It was preparing to transition away from its partnership with Emerald Health Therapeutics, Inc. (CSE: EMH).

Until now, HYTN’s cannabis-infused carbonated beverages sales had been made through its partnership with Emerald in British Columbia, Alberta, Saskatchewan, Ontario and Québec.

HYTN has ensured minimal disruption to its provincial partners and consumers during the transition away from Emerald and has prepared to accept orders from new markets, including Nova Scotia and the Yukon.

“Our team has done incredible work getting us to this point,” said HYTN CEO Elliot McKerr.

“Now that our partnership with Emerald has completed, we are in a strong position to recapture margin and advance our product offerings into new markets,” added McKerr.

While HYTN has begun to accept orders directly, it will continue to work with Emerald to ensure that all products currently in the market are seamlessly transitioned.

Consumers will experience no change in HYTN’s products beyond an update to the manufacturer of record on the label.

HYTN formulates, manufactures, markets, and sells premium cannabis goods.

With the mission to be the leading provider of consistent, natural, and delicious cannabis products, HYTN focuses its efforts on identifying category opportunities and takes an innovative approach to deliver elevated cannabis experiences to a discerning customer base.

HYTN Innovations Inc. (HYTN) is trading at C$0.25 at 12:19 pm ET.

Related News